Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

N-Acetyl Cysteine and Improved Thiol Group Level

Doses used in studies

mg/day: 1,200 (median 1,200, IQR 1,200–1,200) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

1 of 1 paper

A Pilot Study to Evaluate the Effects of Oral N-Acetyl Cysteine on Inflammatory and Oxidative Stress Biomarkers in Rheumatoid Arthritis.
- 2019-07-31
- RCT · n = 23
- Current rheumatology reviews 15(3)
- - Ghazal Hashemi
  - Mahtabalsadat Mirjalili
  - Zahra Basiri
  - Ahmad Tahamoli-Roudsari
  - Nejat Kheiripour
  - Maryam Shahdoust
  - Akram Ranjbar
  - Maryam Mehrpooya
  - Sara Ataei
- PubMed: 30255760
- DOI: 10.2174/1573403x14666180926100811
10 Insights on
- Improved Thiol Group Level
- High evidence
- Clinical
only NO, MDA and TTG showed a significant difference in the NAC group as compared to the placebo group at the end of study
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
600 mg twice daily